180 related articles for article (PubMed ID: 1721292)
1. Rapamycin inhibits spontaneous and fibroblast growth factor beta-stimulated proliferation of endothelial cells and fibroblasts.
Akselband Y; Harding MW; Nelson PA
Transplant Proc; 1991 Dec; 23(6):2833-6. PubMed ID: 1721292
[No Abstract] [Full Text] [Related]
2. Inhibition by rapamycin of PDGF- and bFGF-induced human tenon fibroblast proliferation in vitro.
Salas-Prato M; Assalian A; Mehdi AZ; Duperré J; Thompson P; Brazeau P
J Glaucoma; 1996 Feb; 5(1):54-9. PubMed ID: 8795734
[TBL] [Abstract][Full Text] [Related]
3. Effects of rapamycin on growth factor-stimulated vascular smooth muscle cell DNA synthesis. Inhibition of basic fibroblast growth factor and platelet-derived growth factor action and antagonism of rapamycin by FK506.
Cao W; Mohacsi P; Shorthouse R; Pratt R; Morris RE
Transplantation; 1995 Feb; 59(3):390-5. PubMed ID: 7532879
[TBL] [Abstract][Full Text] [Related]
4. FK 506, rapamycin, and cyclosporine: effects on IL-4 and IL-10 mRNA levels in a T-helper 2 cell line.
Wang SC; Zeevi A; Jordan ML; Simmons RL; Tweardy DJ
Transplant Proc; 1991 Dec; 23(6):2920-2. PubMed ID: 1721312
[No Abstract] [Full Text] [Related]
5. In vivo immunopharmacology of the macrolides FK 506 and rapamycin: toward the era of rational immunosuppressive drug discovery, development, and use.
Morris RE
Transplant Proc; 1991 Dec; 23(6):2722-4. PubMed ID: 1721257
[No Abstract] [Full Text] [Related]
6. Mechanisms of action of immunosuppressive agents: cyclosporin A, FK506, and rapamycin.
Bierer BE
Proc Assoc Am Physicians; 1995 Apr; 107(1):28-40. PubMed ID: 8630742
[No Abstract] [Full Text] [Related]
7. Modes of action of FK506, cyclosporin A, and rapamycin.
Morris R
Transplant Proc; 1994 Dec; 26(6):3272-5. PubMed ID: 7527964
[No Abstract] [Full Text] [Related]
8. [Mechanism of action of the new immunosuppressants: cyclosporin A, FK 506 and rapamycin].
Rondeau E
Nephrologie; 1992; 13(3):137. PubMed ID: 1379348
[No Abstract] [Full Text] [Related]
9. The inhibition of T-cell-receptor-induced Fas ligand upregulation by cyclosporine and FK 506.
Nakajima H; Oka T
Transplant Proc; 1996 Apr; 28(2):1052-5. PubMed ID: 8623224
[No Abstract] [Full Text] [Related]
10. The interaction of immunosuppressive compounds in tandem stimulated peripheral human lymphocytes.
Weaver JL; Pine PS; Aszalos A
Immunopharmacol Immunotoxicol; 1994 May; 16(2):179-90. PubMed ID: 7521360
[TBL] [Abstract][Full Text] [Related]
11. Mechanism of action of rapamycin (Sirolimus, Rapamune).
Molnar-Kimber KL
Transplant Proc; 1996 Apr; 28(2):964-9. PubMed ID: 8623482
[No Abstract] [Full Text] [Related]
12. Inhibition by rapamycin of ornithine decarboxylase and epithelial cell proliferation in intestinal IEC-6 cells in culture.
Seidel ER; Ragan VL
Br J Pharmacol; 1997 Feb; 120(4):571-4. PubMed ID: 9051292
[TBL] [Abstract][Full Text] [Related]
13. The effects of FK 506, cyclosporine, and rapamycin on liver growth in vitro and in vivo.
Francavilla A; Starzl TE; Carr B; Azzarone A; Carrieri G; Zeng QH; Porter KA
Transplant Proc; 1991 Dec; 23(6):2817-20. PubMed ID: 1721287
[No Abstract] [Full Text] [Related]
14. Effects of treatment with cyclosporine, FK 506, rapamycin, mycophenolic acid, or deoxyspergualin on vascular muscle proliferation in vitro and in vivo.
Gregory CR; Pratt RE; Huie P; Shorthouse R; Dzau VJ; Billingham ME; Morris RE
Transplant Proc; 1993 Feb; 25(1 Pt 1):770-1. PubMed ID: 7679842
[No Abstract] [Full Text] [Related]
15. Rapamycin (Sirolimus) inhibits vascular smooth muscle DNA synthesis in vitro and suppresses narrowing in arterial allografts and in balloon-injured carotid arteries: evidence that rapamycin antagonizes growth factor action on immune and nonimmune cells.
Morris RE; Cao W; Huang X; Gregory CR; Billingham ME; Rowan R; Shorthouse RA
Transplant Proc; 1995 Feb; 27(1):430-1. PubMed ID: 7879049
[No Abstract] [Full Text] [Related]
16. Effect of immunosuppressive drugs (CsA, FK 506, rapamycin) on the kidney microsomal cytochrome P-450 system in the rat.
Yoshimura R; Yoshimura N; Ohmachi T; Nakatani T; Ohyama A; Miyao Y; Yamamoto K; Kishimoto T
Transplant Proc; 1994 Oct; 26(5):2890. PubMed ID: 7524223
[No Abstract] [Full Text] [Related]
17. The hydroxylamine of sulfamethoxazole synergizes with FK506 and cyclosporin A, inhibiting T-cell proliferation.
Hess DA; Bird IA; Almawi WY; Rieder MJ
J Pharmacol Exp Ther; 1997 Apr; 281(1):540-8. PubMed ID: 9103542
[TBL] [Abstract][Full Text] [Related]
18. Effect of immunosuppressive drugs on cytokine gene transcription studied by message amplification phenotyping (MAPPing) polymerase chain reaction.
Nelson PA; Kawamura A; Akselband Y; Peattie DA; Aldape RA; Harding MW
Transplant Proc; 1991 Dec; 23(6):2867-9. PubMed ID: 1721299
[No Abstract] [Full Text] [Related]
19. FK 506 and rapamycin do not affect platelet aggregation or mitochondrial function.
Pelekanou V; Trezise AE; Moore AL; Kay JE
Transplant Proc; 1991 Dec; 23(6):3200-1. PubMed ID: 1721408
[No Abstract] [Full Text] [Related]
20. Effects of rapamycin on hematopoiesis.
Quesniaux VF; Wehrli S; Wioland C; Schuler W; Schreier MH
Transplant Proc; 1994 Dec; 26(6):3135-40. PubMed ID: 7998093
[No Abstract] [Full Text] [Related]
[Next] [New Search]
